13F Insight
DOSSIER · 13F-HR · Q3 2025

Skorpios Trust

$53M in tracked AUM across 2 positions as of Q3 2025.

ST
CIK 0001869333 · last filed Sep 30, 2025
Total AUM
$53M
as of Q3 2025
Holdings
2
—
positions
Whale Score
57
57
tracked
Activity
—
no data
changes this Q
AI Analysis · Q3 2025

Portfolio Overview

Skorpios Trust exhibits an extremely high-risk, concentrated investment strategy with minimal diversification. As of the reporting period ending September 30, 2025, the firm manages approximately $53.19 million across just two holdings. The portfolio experienced significant growth of 43.4% during the quarter, increasing from $37.10 million to $53.19 million. This surge in value appears to be driven primarily by market appreciation of the core asset rather than capital inf...

Key Holdings

The portfolio is overwhelmingly dominated by Stoke Therapeutics Inc. (STOK), which accounts for $53.02 million or 99.68% of the total assets. The position consists of 2.26 million shares. This massive weighting indicates that Skorpios Trust is not a diversified fund in the traditional sense but operates more like a focused vehicle or a co-investment partner with a specific conviction in this specific healthcare company.

Quarter at a glance — Q3 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q3 2025.

#HoldingValueSharesWeight
01
STOK
STOKE THERAPEUTICS INC
$53M2.3M99.7%02
XBI
SPDR SER TR
$169K2K0.3%

Filing history

2025Q3Sep 30
$53M▲ 43.4%
2 positionsView →2025Q2Jun 30
$37M▼ 19.5%
2 positionsLocked2025Q1Mar 31
$46M▼ 39.7%
2 positionsLocked2024Q4Dec 31
$76M▼ 30.4%
2 positionsLocked2024Q3Sep 30
$110M▼ 25.3%
2 positionsLocked2024Q2Jun 30
$147M▼ 24.9%
2 positionsLocked2024Q1Mar 31
$195M▲ 156.4%
2 positionsLocked2023Q4Dec 31
$76M▲ 33.5%
2 positionsLocked2023Q3Sep 30
$57M▼ 75.2%
2 positionsLocked2023Q2Jun 30
$230M▼ 6.9%
4 positionsLocked2023Q1Mar 31
$247M▼ 21.3%
4 positionsLocked2022Q4Dec 31
$314M▼ 11.3%
4 positionsLocked
Showing 12 of 16